Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) Earnings Report Expected In 2 Days

Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN)

August 4th, 2018

Amidst rising markets Achillion Pharmaceuticals, Inc. fell $0.07 Thursday which equals a 2.72% decline, closing at $2.50. With an estimated two days to the next earnings report, everyone is watching Achillion Pharmaceuticals, Inc.. As well as the drop in value, Achillion Pharmaceuticals, Inc. hit a new 52 week low of $2.48, breaking the previous low of $2.50 from earlier this month. Be aware that the Piotroski Score1 is calculated to be 2, which is very low as the scale goes from 0-9. This is considered to be a weak score in terms of financial strength.

ACHN was outperformed by the rest of the Healthcare sector which went up 0.64%.

Achillion Pharmaceuticals, Inc. Info

Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes small molecule drug therapies for immune system disorders in the United States. Its lead drug candidate includes ACH-4471, an inhibitor of factor D that is Phase II clinical trials for patients with paroxysmal nocturnal hemoglobinuria and C3 glomerulopathy. The company is also developing ACH-5228, a factor D inhibitor that is in Phase I clinical trial; ACH-5548, a factor D inhibitor; and other factor D inhibitors. It has license agreements with GCA Therapeutics, Ltd and Ora, Inc., as well as a collaboration arrangement with Janssen Pharmaceuticals Inc. to develop and commercialize drug candidates for the treatment of chronic hepatitis C virus. The company was founded in 1998 and is headquartered in New Haven, Connecticut.

All amounts in USD unless otherwise indicated

(1) The Piotrosky score is used to determine the best value stocks with nine being the best and zero being the worst. It is based on specific aspects of the company’s financial statements, such as positive net income, operating cash flow and asset turnover ratio. A score 0 0 is the worst (Achillion Pharmaceuticals, Inc.’s score is ), and 9 is the best.

ACHN daily update
ACHN daily update

Media Gazelle Inc (MG), a Nevada Corporation, owns and operates the online brand US Tribune News. MG does not offer financial advise, and is not a registered broker/dealer/analyst/adviser, holds no investment licenses, and may not sell, offer to sell or offer to buy any security. MG’s market updates, news are not a solicitation or recommendation to buy, sell or hold securities. MG shall not be held liable for any investment losses you may incur by using the information provided, this includes you trading the stocks mentioned on our sites. We recommend you talk to a financial adviser before trading any securities or taking any action based upon information on this site. MG does not guarantee the accuracy of the article.